GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $2,557,000 | -61.9% | 22,160 | -67.9% | 0.07% | -70.5% |
| Q3 2020 | $6,715,000 | -11.8% | 68,980 | +11.2% | 0.25% | -25.1% |
| Q2 2020 | $7,611,000 | +61.8% | 62,020 | +15.4% | 0.34% | +22.3% |
| Q1 2020 | $4,705,000 | -28.5% | 53,730 | -14.6% | 0.27% | +3.4% |
| Q4 2019 | $6,578,000 | -3.2% | 62,910 | +6.5% | 0.26% | -14.8% |
| Q3 2019 | $6,793,000 | -28.4% | 59,050 | +7.2% | 0.31% | -26.1% |
| Q2 2019 | $9,492,000 | +51.2% | 55,060 | +47.8% | 0.42% | +52.5% |
| Q1 2019 | $6,279,000 | +108.2% | 37,250 | +20.3% | 0.28% | +76.9% |
| Q4 2018 | $3,016,000 | -49.4% | 30,970 | -10.2% | 0.16% | -39.3% |
| Q3 2018 | $5,958,000 | +84.3% | 34,490 | +48.9% | 0.26% | +87.6% |
| Q2 2018 | $3,233,000 | – | 23,170 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 86,069 | $18,668,000 | 8.69% |
| BARDIN HILL MANAGEMENT PARTNERS LP | 170,108 | $36,897,000 | 6.84% |
| HARVEST MANAGEMENT LLC | 44,100 | $9,565,000 | 5.72% |
| Twin Securities, Inc. | 39,541 | $8,576,000 | 5.50% |
| TIG Advisors, LLC | 572,743 | $124,228,000 | 4.67% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 787,500 | $170,810,000 | 4.63% |
| First Trust Capital Management L.P. | 105,822 | $22,953,000 | 4.49% |
| Pentwater Capital Management LP | 2,102,104 | $455,946,000 | 4.35% |
| OMNI PARTNERS LLP | 403,061 | $87,424,000 | 4.31% |
| SPRING CREEK CAPITAL LLC | 370,000 | $80,253,000 | 3.47% |